Log In
Print
BCIQ
Print
Print this Print this
 

Recomodulin (ART-123)

  Manage Alerts
Collapse Summary General Information
Company Asahi Kasei Pharma Corp.
DescriptionSoluble form of recombinant human thrombomodulin alpha
Molecular Target Thrombin (Factor IIa) (F2) ; High mobility group box 1 (HMGB1)
Mechanism of ActionThrombin inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today